Sat.Feb 27, 2021 - Fri.Mar 05, 2021

article thumbnail

Disney characters will lend a hand to kids during MRI scans

pharmaphorum

Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid. Healthcare tech company Philips has teamed up with Walt Disney Corp to develop custom ambient animations – featuring some of the most-lived characters from Disney, Marvel and Star Wars shows – that can be played to children during the procedure.

Hospitals 132
article thumbnail

Inside the Pfizer/BioNTech COVID-19 vaccine trial: ‘We knew the world was watching and waiting for results’

Outsourcing Pharma

The 2020 Pfizer/BioNTech COVID-19 vaccine trial recruited more than 44,000 participants and reached submission for emergency authorization in 248 days: showing unprecedented speed and agility in the context of a global pandemic. So what have been the learnings from the trial â and how could they be applied to vaccine development in the future?

Vaccines 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can you get melatonin over the counter in the UK?

Druggist

Melatonin is a hormone that is released at night by the pineal gland located in the brain. Melatonin controls the sleep-wake cycle (24-hour cycle). In other words, melatonin acts as a biological clock that regulates sleep. Melatonin, therefore, can be used to promote and regulate sleep (Wagner et al., 1998). This post answers the question: Can you get melatonin over the counter in the UK?

article thumbnail

DarshanTalks: Blockchain & Information Technology – March 1, 2021

Pharma Marketing Network

[link]. Blockchain technology has become an increasing tool for life science organizations. How is this technology being implemented, and what value does it offer? Join Darshan Kulkarni as he talks with guest Jim Nasr about the function of blockchain, and how distributed ledger technologies such as blockchain are making an impact on healthcare. The post DarshanTalks: Blockchain & Information Technology</br> – March 1, 2021 appeared first on Pharma Marketing Network.

97
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How accidental advocacy is amplifying the GM1 voice

pharmaphorum

Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner. She spoke to pharmaphorum as part of our Patients Insights series. Like many “rare disease mums”, Christine is an accidental advocate. After her daughter, Iris, was diagnosed with a rare disease at five, friends, family, and strangers donated so much to a research fund-raising campaign that she had to set up a non-profit to deal with it all.

126
126
article thumbnail

Prostate cancer drug demonstrates major survival benefit

Outsourcing Pharma

According to Noxopharm, a recent study shows combining its Veyonda drug and a radiopharmaceutical yields favorable results against prostate cancer.

105
105

More Trending

article thumbnail

Understanding and Adapting to the New Patient Journey

Pharma Marketing Network

We’ve talked before about how COVID-19 has upended our personal and business lives, and how the pharma industry was able to – impressively – shift gears to meet the challenges the pandemic brought. But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative?

article thumbnail

How clinical trial software can be used to optimize clinical trials

pharmaphorum

Clinical trial software facilitates clinical trials from conception to finish. For example protocol management, CRF design , metadata management, and the collection, analysis, and submission of compliant clinical study data to regulatory authorities. The aim is to get quality clinical products to the market faster. Traditionally spreadsheets have been used to record and manage all the various aspects of clinical trials.

article thumbnail

Genetic services can overcome rare disease trial challenges: InformedDNA

Outsourcing Pharma

A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients.

98
article thumbnail

I Holland Announces a New Leadership Team

Pharma Mirror

I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets, has announced a series of appointments to form a new senior management team to lead the company moving forward. The new Board of Directors consists of six highly-experienced team members many of which remain from the previous management team. David Hinds has handed over the baton of Managing Director to Javier Raposo but will continue to serve on the Board as Non-Executive Director.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Understanding and Adapting to the New Patient Journey

Pharma Marketing Network

We’ve talked before about how COVID-19 has upended our personal and business lives, and how the pharma industry was able to – impressively – shift gears to meet the challenges the pandemic brought. But what about patients? And what about the disrupted patient journey? What can our industry do to ensure patients maintain continuity of care at a time when good health is imperative?

article thumbnail

Novavax in talks with FDA over quick approval for COVID-19 shot

pharmaphorum

Novavax hopes its COVID-19 vaccine could be filed in the US in the second quarter, following a potential approval from the UK regulator in the coming weeks. The timetable for approval from the FDA depends on whether the regulator accepts data from the company’s trial in the UK, which could set up a potential Emergency Use Authorisation. Following an upbeat Q4 results announcement CEO Stanley Erck told CNBC that discussions with the FDA are ongoing but the hope is that the regulator will accept t

FDA 113
article thumbnail

US Army taps PPD to conduct PTSD treatment research

Outsourcing Pharma

The CRO will receive funding to fuel a five-year Research Project Award, with the goal to design and conduct research of potential PTSD treatment options.

95
article thumbnail

How Much Melatonin is Safe to Take?

BuzzRx

Melatonin is a hormone naturally produced by the central nervous system in the pineal gland, which is located in the brain. Melatonin release is correlated with the time of day. For example, melatonin levels are lowest during the day and peak during the evening when it is dark. Melatonin secretion regulates the body’s circadian rhythms while synchronizing the sleep-wake cycle throughout the day.

Dosage 52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Novartis Piqray(R) – First and only treatment specially for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer receives HSA approval

Pharma Mirror

Novartis announced the Health Sciences Authority (HSA) has approved* Piqray®, an ?-specific class I phosphatidylinositol-3-kinase (PIK3CA) inhibitor, for the treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2-) negative, advanced breast cancer with a PIK3CA mutation in combination with fulvestrant after disease progression following an endocrine-based regimen.

52
article thumbnail

GSK hits trouble with Trelegy as EU regulators block asthma indication

pharmaphorum

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups. It’s a blow for GSK, which hopes that Trelegy (fluticasone furoate+umeclidinium+vilanterol) will help to revive the fortunes of its respiratory diseases franchise.

Labelling 105
article thumbnail

Shimmer launches upgraded wearable for remote patient monitoring

Outsourcing Pharma

The Verisense Pulse+ can measure heart rate, oxygen saturation, emotional responses, and activity and sleep levels of at-home clinical trial participants.

55
article thumbnail

Medications For Weight Loss – Clinical Breakdown

Med Ed 101

Obesity is a major risk factor for many comorbidities (hypertension, dyslipidemia, osteoarthritis, sleep apnea, heart disease, type 2 diabetes) and increases all-cause and cardiovascular mortality. With over 40% of Americans qualifying as obese (body mass index ?30 kg/m2) in 2017-18 it is no surprise that weight loss remains a hot ticket item today.

40
article thumbnail

Accelerating Investigator Recruitment with NLP

Pharma Mirror

NLP and social graphs are effective instruments to speed up investigator recruitment and ensure timely pharmaceutical product releases. Read how NLP can leverage the power of unstructured data and help find doctors-influencers that can substantially provide assistance to a clinical trial. Igor Kruglyak is a Senior Advisor at the global IT service provider Avenga and a 35+ year veteran executive of global key development and deployment projects.

52
article thumbnail

Budget 2021: Sunak focuses on vaccine development to restart economy

pharmaphorum

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role. The ongoing fight against COVID-19 was a top-line feature of the budget announcement, with an extra £1.65bn to ensure the vaccination roll-out continues to be a success.

Vaccines 105
article thumbnail

Syneos, Protocol First to collaborate on trial data solutions

Outsourcing Pharma

The partnership reportedly will center on optimizing integration for EHR data and remote-source data review to help accelerate clinical research results.

52
article thumbnail

Semaglutide For Weight Loss – STEP 1 Trial

Med Ed 101

A new treatment for chronic weight management is likely on the way. In a recent trial, investigators looked at semaglutide for weight loss. The final results of the STEP1 trial (Semaglutide Treatment Effect in People with obesity) were recently reported in the New England Journal of Medicine. Semaglutide, a GLP-1 receptor agonist approved for type […].

40
article thumbnail

Genomics plc scores $30m to expand patient-centric health platform

Pharma Times

Latest funding round includes investments from Foresite Capital and F-Prime Capital

49
article thumbnail

Could personalised medicine change treatment for migraine?

pharmaphorum

The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market. Alec Mian, CEO at diagnostics firm Curelator, spoke to pharmaphorum’s news editor Richard Staines about the company’s plans to apply a similar paradigm to other diseases such as migraine. . There has been noticeable progress in migraine as a disease area in the last few years, with a new class of drugs coming to market that could help preven

article thumbnail

Lonza expands solid-form services at Oregon facility

Outsourcing Pharma

The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs.

52
article thumbnail

Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technology

pharmaphorum

In the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO of Owlstone Medical, one of the UK’s most promising diagnostic startups. The Cambridge, UK-based company is on a mission to save 100,000 lives and $1.5bn in healthcare costs with its breath biopsy platform for early detection of cancer. Owlstone is developing a breath-based analyser that captures Volatile Organic Compounds (VOCs) in breath non-invasively, and analyses them with high sensi

article thumbnail

Medable, Seqster pair up on real-world data for remote trials

pharmaphorum

With COVID-19 forcing a shift towards decentralised trials, two digital health firms – Medable and Seqster – have teamed up to offer ways to also incorporate real-world data into remote study designs. . Decentralised studies reduce or eliminate the need to travel to clinical sites, and the two partners want to go even further by harnessing technologies that can provide additional data in real-time to generate “a more holistic view of patient health,” according to Medable CEO Dr Michelle Longmire

98
article thumbnail

Roche introduces 15-minute nasal COVID test in UK

pharmaphorum

Roche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has millions of the kits available straight away to help the country recover from the pandemic. . The speedy test can turn around results within 15 minutes, without the need for processing swabs in a lab, and only requires the front part of the nose to be swabbed, rather than the nasopharynx area where the nose meets the throat.

FDA 98
article thumbnail

ISA plans trials of T-cell boosting COVID-19 therapy

pharmaphorum

ISA Pharmaceuticals is planning to take its COVID-19 immunotherapy into the clinic, aiming to harness the power of T-cells to prevent the disease from becoming serious in infected patients. Based in Leiden, the Netherlands, ISA said it has completed preclinical work on ISA106 and is planning clinical trials with a phase 1 dose-finding study in healthy volunteers due in the next few months.

article thumbnail

Syneos adds to European team with key hires

pharmaphorum

Syneos Health Communications has made several senior hires to strengthen its Europe-based team. A portfolio of Syneos Health agencies, Syneos Health Communications, offers expertise spanning advertising and branding, public relations and medical communications. Orrin Pollard. Among the most notable hires is Orrin Pollard, who joins as director of European creative expression.

article thumbnail

Why AI equity is the next step for transformational pharma

pharmaphorum

AI can be transformative for all areas of healthcare, but often these systems are built off biased datasets that don’t reflect the true diversity of the general public – leading to approaches that only work for specific populations. Intouch Group’s Abid Rahman explains this concept of AI equity and gives some practical tips for how companies can work towards it.

article thumbnail

Numan buys Vi Health to add digital capabilities

pharmaphorum

Numan has added to its digital health stable with the acquisition of Sweden’s Vi Health and its suite of tools including an artificial intelligence-powered symptom checker. . UK-based Numan is in the process of building a digital health platform to provide access to medical professionals as well as information on pharmaceutical products and health conditions, around its core focus of men’s health, wellness and fitness.

72
article thumbnail

Germany backtracks on AZ COVID vaccine age restriction

pharmaphorum

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. . The country’s drugs regulator previously limited use of the vaccine to the under-65s only, claiming that the data in the older age group was inadequate, even though the European Commission had approved the shot for all adults aged over 18.

article thumbnail

AZ sells stake in Moderna for more than $1billion

pharmaphorum

AstraZeneca has sold its stake in Moderna for more than $1 billion as the US biotech’s shares soared in value following its coronavirus vaccine breakthrough. The UK-based pharma has disposed of its 7.7% holding in the mRNA technology pioneer, The Times reported (behind paywall). Moderna was among the first companies to get a COVID-19 vaccine approved and has been selling it at a profit, even though the project was kick-started with around $1.5 billion in US government funding.